AbbVie Inc Stock Performance
as on April 24, 2026 at 4:10 am IST
Day's Low
Day's High
$200.58$202.76
0.10%
Downside
0.98%
Upside
52 Week's Low
52 Week's High
$174.40$244.8113.14%
Downside
21.92%
Upside
AbbVie Inc share price movements today
- Previous Close
- $200.50
- Open
- $201.07
- Volume
- 2.7M
- Day's Low - High
- $200.58 - $202.76
- 52 Week Low - High
- $174.40 - $244.81
AbbVie Inc Historical Returns
- 1 Month Return
- -2.16 %
- 3 Month Return
- -8.56 %
- 1 Year Return
- + 13.24 %
- 3 Year Return
- + 23.45 %
- 5 Year Return
- + 80.01 %
AbbVie Inc Stock Fundamentals & Key Indicators
Check AbbVie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$354.6B
EPS (TTM)
14.2653
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.89%
PE Ratio (TTM)
84.6
Industry PE ratio
28.09
PEG Ratio
0.4709
EBITDA
29.3B
Revenue (TTM)
61.2B
Profit Margin
6.91%
Return On Equity TTM
62.25%
AbbVie Inc Stock Valuation
Track how AbbVie Inc P/E has moved over time to understand its valuation trends.
AbbVie Inc in the last 5 years
Lowest (9.30x)
September 30, 2021
Industry (28.09x)
April 23, 2026
Today (84.60x)
April 23, 2026
Highest (22.78x)
December 31, 2025
Today’s Price to Earnings Ratio: 84.60x
AbbVie Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of AbbVie Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $354.6B | 80.01% | 84.6 | 6.91% | |
| BUY | $303.5B | 272.77% | 29.94 | 17.41% | |
| BUY | $824.7B | 388.28% | 40.17 | 31.67% | |
| BUY | $544.9B | 36.6% | 20.5 | 21.83% | |
| BUY | $279.1B | 44.95% | 15.51 | 28.08% |
Stock Returns calculator for AbbVie Inc Stock including INR - Dollar returns
The AbbVie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
AbbVie Inc investment value today
Current value as on today
₹1,25,015
Returns
₹25,015
(+25.02%)
Returns from AbbVie Inc Stock
₹13,409 (+13.41%)
Dollar Impact
₹11,607 (+11.61%)
Analyst Recommendation on AbbVie Inc Stock
Based on 35 analysts
65.71%
Buy
34.29%
Hold
0.00%
Sell
Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for AbbVie Inc. Average target price of $249.43
AbbVie Inc Share Price Target
Get share price movements and forecasts by analysts on AbbVie Inc.
What analysts predicted
19.5%UPSIDE
Target Price
$249.43
Current Price
$200.79
Analyzed by
35 Analysts
Target
$249.43
AbbVie Inc target price $249.43, a slight upside of 19.5% compared to current price of $200.79. According to 35 analysts rating.
AbbVie Inc Stock’s Investor Sentiment and Interest
Investment in AbbVie Inc Shares on INDmoney has grown by 46.25% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:46.25%Â versus previous 30 day period
Search interest for AbbVie Inc Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:14%Â versus previous 30 day period
AbbVie Inc Quarterly Profit & Loss
All numbers in Millions USD
AbbVie Inc Annual Profit & Loss
All numbers in Millions USD
AbbVie Inc Quarterly Cash Flow
All numbers in Millions USD
AbbVie Inc Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own AbbVie Inc Stock
Check out the Mutual Funds with significant holdings in AbbVie Inc.
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.68503% | 13199 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 2.95075% | 2397 |
Global Institutional Holdings in AbbVie Inc
AbbVie Inc News & Key Events
Today's Timeline - 22 April
Thu, 03:21 AM
-AbbVie enters exclusive licensing agreement with Haisco for pain medicines development, potentially covering multiple compounds.
Thu, 06:39 AM
-AbbVie invests $1.4 billion in a new AI-enabled manufacturing campus in Durham, creating 734 jobs and expanding its oncology pipeline.
Insights on AbbVie Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Abbvie Inc has shown impressive growth in its net profit over the last two quarters. It increased from $186.0 million to $1.81 billion, which translates to an average quarterly growth rate of 89.8%. This indicates strong financial performance and positive trends in profitability for the company.
- POSITIVE IMPACT
Revenue Rich
Abbvie Inc has shown consistent revenue growth over the last four quarters. The company's revenue increased from $13.34 billion to $16.61 billion, reflecting an average growth rate of 6.9% per quarter.
NO EFFECTAgainst Peers
In the last 3 years, ASTRAZENECA PLC has given 157.7% return, outperforming this stock by 134.2%
- NO EFFECT
Against Peers
In the last 1 year, ASTRAZENECA PLC has given 184.4% return, outperforming this stock by 171.2%
NEGATIVE IMPACTPrice Dip
In the last 7 days, ABBV stock has moved down by -4.1%
About AbbVie Inc
| Organisation | AbbVie Inc |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Key Management of AbbVie Inc
Name | Title |
|---|---|
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
Mr. Scott T. Reents | Executive VP & CFO |
Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO |
Dr. Roopal B. Thakkar M.D. | Executive VP of Research & Development and Chief Scientific Officer |
Ms. Linda Ray | Senior VP & Chief Information Officer |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
FAQs
What is AbbVie Inc share price today?
AbbVie Inc share price today is $200.79 as on . AbbVie Inc share today touched a day high of $202.76 and a low of $200.58.
What is the 52 week high and 52 week low for AbbVie Inc share?
AbbVie Inc share touched a 52 week high of $244.81 on and a 52 week low of $174.4 on . AbbVie Inc stock price today i.e. is trending at $200.79,which is 17.98% down from its 52 week high and 15.13% up from its 52 week low.
What is AbbVie Inc's market capitalisation today?
AbbVie Inc market capitalisation is $0.35T as on .
How to invest in AbbVie Inc Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for AbbVie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AbbVie Inc Shares that will get you 0.0075 shares as per AbbVie Inc share price of $200.79 per share as on April 23, 2026 at 10:40 pm IST.
What is the minimum amount required to buy AbbVie Inc Stock (ABBV) from India?
Indian investors can start investing in AbbVie Inc (ABBV) shares with as little as ₹94.085 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.85 in AbbVie Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on AbbVie Inc share’s latest price of $200.79 as on April 23, 2026 at 10:40 pm IST, you will get 0.0498 shares of AbbVie Inc. Learn more about
fractional shares .
What are the returns that AbbVie Inc has given to Indian investors in the last 5 years?
AbbVie Inc stock has given 80.01% share price returns and 24.28% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?